GKOS - GLAUKOS Corp

107.73
-4.370   -4.056%

Share volume: 622,283
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$112.10
-4.37
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
29%
Profitability 6%
Dept financing 30%
Liquidity 61%
Performance 44%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-11.06%
1 Month
-4.89%
3 Months
-0.67%
6 Months
17.25%
1 Year
3.40%
2 Year
21.17%
Key data
Stock price
$107.73
P/E Ratio 
0.00
DAY RANGE
$106.50 - $110.02
EPS 
-$3.28
52 WEEK RANGE
$73.16 - $130.23
52 WEEK CHANGE
$11.44
MARKET CAP 
6.485 B
YIELD 
N/A
SHARES OUTSTANDING 
58.079 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.60
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$646,456
AVERAGE 30 VOLUME 
$762,063
Company detail
CEO: Thomas W. Burns
Region: US
Website: glaukos.com
Employees: 780
IPO year: 2015
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally.

Recent news